FT

AstraZeneca’s US trial shows 79% efficacy against Covid

Photo of Financial Times Financial Times
0 Less than a minute

Monitoring board found no increased risk of thrombosis among participants receiving at least one dose

Photo of Financial Times Financial Times
0 Less than a minute
Photo of Financial Times

Financial Times

Related Articles

EU seeks new post-Trump alliance with US in face of China challenge

Trump campaign escalates legal offensive in several states

AstraZeneca chief suffers investor rebellion over pay

ECB squashes Deutsche Bank plans to raise bonus pool by a third

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button